Multi-therapeutic approach to manage delivery in an alloimmunized patient with type 3 von Willebrand disease
- 1 January 2003
- journal article
- website
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (1) , 190-192
- https://doi.org/10.1046/j.1538-7836.2003.00009.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Continuous Infusion of Recombinant Factor VIIa (NovoSeven®) in the Treatment of a Patient with Type III von Willebrand’s Disease and Alloantibodies against von Willebrand FactorThrombosis and Haemostasis, 2000
- Recombinant Factor VIIa Is a Pan-hemostatic Agent?Thrombosis and Haemostasis, 2000
- Alloantibody from a patient with severe von Willebrand disease inhibits von Willebrand factor-FVIII interactionAnnals of Hematology, 1997
- A Revised Classification of von Willebrand DiseaseThrombosis and Haemostasis, 1994
- Therapeutic protein A immunoadsorption. A reviewTransfusion Science, 1990
- Life‐threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factorEuropean Journal of Haematology, 1987
- Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogsFertility and Sterility, 1983
- Precipitating antibodies to factor VIII/von Willebrand factor in von Willebrand's disease: effects on replacement therapyBlood, 1981